(1)
Putri, A.; Rinaldi, I.; Louisa, M.; Koesnoe, S. The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients. Acta Med Indones 2020, 51, 348.